191 related articles for article (PubMed ID: 36084618)
1. COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.
Lee LYW; Ionescu MC; Starkey T; Little M; Tilby M; Tripathy AR; Mckenzie HS; Al-Hajji Y; Appanna N; Barnard M; Benny L; Burnett A; Cattell EL; Clark JJ; Khan S; Ghafoor Q; Panneerselvam H; Illsley G; Harper-Wynne C; Hattersley RJ; Lee AJ; Lomas O; Liu JK; McCauley A; Pang M; Pascoe JS; Platt JR; Patel G; Patel V; Potter VA; Randle A; Rigg AS; Robinson TM; Roques TW; Roux RL; Rozmanowski S; Taylor H; Tuthill MH; Watts I; Williams S; Beggs A; Iveson T; Lee SM; Middleton G; Middleton M; Protheroe A; Fittall MW; Fowler T; Johnson P;
Eur J Cancer; 2022 Nov; 175():1-10. PubMed ID: 36084618
[TBL] [Abstract][Full Text] [Related]
2. Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.
Lee LYW; Starkey T; Ionescu MC; Little M; Tilby M; Tripathy AR; Mckenzie HS; Al-Hajji Y; Barnard M; Benny L; Burnett A; Cattell EL; Charman J; Clark JJ; Khan S; Ghafoor Q; Illsley G; Harper-Wynne C; Hattersley RJ; Lee AJX; Leonard PC; Liu JKH; ; Pang M; Pascoe JS; Platt JR; Potter VA; Randle A; Rigg AS; Robinson TM; Roques TW; Roux RL; Rozmanowski S; Tuthill MH; Watts I; Williams S; Iveson T; Lee SM; Middleton G; Middleton M; Protheroe A; Fittall MW; Fowler T; Johnson P
Lancet Oncol; 2022 Jun; 23(6):748-757. PubMed ID: 35617989
[TBL] [Abstract][Full Text] [Related]
3. Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
Abu-Raddad LJ; Chemaitelly H; Ayoub HH; AlMukdad S; Yassine HM; Al-Khatib HA; Smatti MK; Tang P; Hasan MR; Coyle P; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R
N Engl J Med; 2022 May; 386(19):1804-1816. PubMed ID: 35263534
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
[TBL] [Abstract][Full Text] [Related]
5. Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.
Shrotri M; Krutikov M; Nacer-Laidi H; Azmi B; Palmer T; Giddings R; Fuller C; Irwin-Singer A; Baynton V; Tut G; Moss P; Hayward A; Copas A; Shallcross L
Lancet Healthy Longev; 2022 Jul; 3(7):e470-e480. PubMed ID: 35813279
[TBL] [Abstract][Full Text] [Related]
6. Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial.
Thakkar A; Pradhan K; Duva B; Carreno JM; Sahu S; Thiruthuvanathan V; Campbell S; Gallego S; Bhagat TD; Rivera J; Choudhary G; Olea R; Sabalza M; Shapiro LC; Lee M; Quinn R; Mantzaris I; Chu E; Will B; Pirofski LA; Krammer F; Verma A; Halmos B
Elife; 2023 Mar; 12():. PubMed ID: 36975207
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
[TBL] [Abstract][Full Text] [Related]
8. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
10. Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study.
Chemaitelly H; Ayoub HH; Tang P; Coyle P; Yassine HM; Al Thani AA; Al-Khatib HA; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Faust JS; Abu-Raddad LJ
Lancet Infect Dis; 2023 Jul; 23(7):816-827. PubMed ID: 36913963
[TBL] [Abstract][Full Text] [Related]
11. Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study.
Nelli F; Fabbri A; Virtuoso A; Giannarelli D; Giron Berrios JR; Marrucci E; Fiore C; Schirripa M; Signorelli C; Chilelli MG; Primi F; Pessina G; Natoni F; Silvestri MA; Ruggeri EM
Curr Oncol; 2023 May; 30(5):5103-5115. PubMed ID: 37232844
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron.
Meeraus W; Stuurman AL; Durukal I; Conde-Sousa E; Lee A; Maria AS; Furtado BE; Ouwens M; Gray CM; Valverde DA; da Silva HG; Taylor S
Vaccine; 2023 Oct; 41(42):6366-6378. PubMed ID: 37704499
[TBL] [Abstract][Full Text] [Related]
13. Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022.
Chatzilena A; Hyams C; Challen R; Marlow R; King J; Adegbite D; Kinney J; Clout M; Maskell N; Oliver J; Finn A; Danon L;
Euro Surveill; 2023 Nov; 28(48):. PubMed ID: 38037728
[TBL] [Abstract][Full Text] [Related]
14. Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland.
Anderegg N; Althaus CL; Colin S; Hauser A; Laube A; Mäusezahl M; Wagner M; Zaffora B; Riou J
Swiss Med Wkly; 2022 Apr; 152():w30163. PubMed ID: 35752951
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
Kirsebom FCM; Stowe J; Lopez Bernal J; Allen A; Andrews N
J Infect; 2024 Jul; 89(1):106177. PubMed ID: 38719110
[TBL] [Abstract][Full Text] [Related]
16. Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study.
Kirsebom FCM; Andrews N; Stowe J; Ramsay M; Lopez Bernal J
Lancet Infect Dis; 2023 Nov; 23(11):1235-1243. PubMed ID: 37453440
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of vaccination for preventing hospitalisation with COVID-19 in regional Queensland: a data linkage study.
Smoll NR; Al Imam MH; Shulz C; Booy R; Khandaker G
Med J Aust; 2023 Aug; 219(4):162-165. PubMed ID: 37400415
[TBL] [Abstract][Full Text] [Related]
19. Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study.
Wan J; Cazer CL; Clarkberg ME; Henderson SG; Lee SE; Meredith GR; Osman M; Shmoys DB; Frazier PI
PLoS Med; 2023 Jan; 20(1):e1004153. PubMed ID: 36626376
[TBL] [Abstract][Full Text] [Related]
20. Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study.
Wright BJ; Tideman S; Diaz GA; French T; Parsons GT; Robicsek A
Lancet Respir Med; 2022 Jun; 10(6):557-565. PubMed ID: 35227415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
